SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/02/21 YIELD10 Bioscience, Inc. 424B5 1:902K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 424B5 Prospectus - Primary Offering or Shelf Securities HTML 449K - New Facts or Events
tm213717-2_424b5 - none - 5.2657184s |
| | ||||||||||||||
| | | |
Per Share
|
| | |
Total
|
| ||||||
Public offering price
|
| | | | $ | 12.25 | | | | | | $ | 12,740,000 | | |
Underwriting fees(1)
|
| | | | $ | 0.86 | | | | | | $ | 543,998 | | |
Proceeds, before expenses, to Yield10 Bioscience
|
| | | | $ | 11.39 | | | | | | $ | 12,196,002 | | |
| | |
Page
|
| |||
| | | | S-2 | | | |
| | | | S-2 | | | |
| | | | S-4 | | | |
| | | | S-8 | | | |
| | | | S-9 | | | |
| | | | S-27 | | | |
| | | | S-28 | | | |
| | | | S-29 | | | |
| | | | S-47 | | | |
| | | | S-51 | | | |
| | | | S-55 | | | |
| | | | S-59 | | | |
| | | | S-59 | | | |
| | | | S-60 | | | |
| | | | S-60 | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 5 | | | |
| | | | | 5 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 11 | | | |
| | | | | 12 | | | |
| | | | | 12 | | | |
| | | | | 13 | | | |
| | | | | 13 | | |
|
Public offering price
|
| | | | | | | | | $ | 12.25 | | |
|
Net tangible book value per share as of September 30, 2020
|
| | | $ | 3.56 | | | | | | | | |
|
Increase in net tangible book value per share attributable to new investors
|
| | | $ | 1.90 | | | | | | | | |
|
Adjusted net tangible book value per share after giving effect to the offering
|
| | | | | | | | | $ | 5.46 | | |
|
Dilution per share to new investors in this offering
|
| | | | | | | | | $ | 6.79 | | |
Name
|
| |
Number of Shares
|
| |||
Maxim Group LLC
|
| | | | 1,040,000 | | |
Total
|
| | | | 1,040,000 | | |
| | |
Per Share
|
| |
Total
|
| ||||||
Public offering price
|
| | | $ | 12.25 | | | | | $ | 12,740,000 | | |
Underwriting discount (7%)
|
| | | $ | 0.86 | | | | | $ | 543,998 | | |
Proceeds, before expense, to us
|
| | | $ | 11.39 | | | | | $ | 12,196,002 | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 5 | | | |
| | | | | 5 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 11 | | | |
| | | | | 12 | | | |
| | | | | 12 | | | |
| | | | | 13 | | | |
| | | | | 13 | | |
This ‘424B5’ Filing | Date | Other Filings | ||
---|---|---|---|---|
5/19/27 | ||||
9/11/24 | ||||
1/7/24 | ||||
12/21/22 | ||||
5/19/22 | ||||
2/3/21 | 4 | |||
Filed on: | 2/2/21 | 8-K | ||
1/31/21 | 8-K | |||
1/28/21 | ||||
1/26/21 | ||||
12/31/20 | 10-K, 4 | |||
12/6/20 | ||||
11/12/20 | 10-Q, 8-K | |||
9/30/20 | 10-Q, 4 | |||
8/26/20 | 4 | |||
6/22/20 | ||||
4/10/20 | EFFECT | |||
4/1/20 | S-3 | |||
3/30/20 | CORRESP, UPLOAD | |||
3/20/20 | ||||
3/4/20 | ||||
1/30/20 | 4 | |||
1/15/20 | 8-K | |||
1/9/20 | 4, 8-K, S-8 | |||
12/31/19 | 10-K | |||
12/23/19 | ||||
6/25/19 | 8-K, SC 13D/A | |||
12/31/18 | 10-K, 4, 5 | |||
12/18/18 | ||||
5/17/18 | ||||
1/7/18 | ||||
12/21/17 | 8-K | |||
9/12/17 | ||||
7/3/17 | 4, 8-K | |||
6/30/15 | 10-Q | |||
List all Filings |